The differentiation program for these T helper cell subsets can be influenced by a number of factors, including the dose and form of antigen, the antigen-presenting cell and/or costimulatory molecules; however, the dominant regulators of T helper cell differentiation are undoubtedly cytokines (reviewed in [3, [5] [6] [7] ). In addition to the expression of a distinct set of cytokine genes, the molecular basis for commitment to a Th1 or Th2 phenotype can probably be explained by a variety of mechanisms, including differential cytokine signaling, exclusive cytokine receptor expression, differential expression of transcription factors, and/or differential chromatin remodeling of Th1-and Th2-specific genes [3, [8] [9] [10] . Significant progress has been made in identifying the transcription factors that control the development of Th2 cells (reviewed in [3, 8, 9, 11] ), but very little was known about the molecular basis of Th1 differentiation until recently. Szabo et al. [12] now report the isolation of T-bet, a novel Th1-specific transcription factor that controls the expression of the hallmark Th1 cytokine, IFN-g.
Remarkably, this group found that ectopic expression of T-bet could not only induce endogenous IFN-g production when introduced at an early stage into developing Th2 cells, but could also induce IFN-g production and repress IL-4 and IL-5 production in otherwise committed Th2 cells.
Th1-and Th2-specific cytokines can augment the growth or differentiation of their respective subset, and additionally may inhibit the development of the opposing subset ( Figure 1 ). The development of Th1 cells from an antigenically naïve CD4 + T-cell precursor is driven by IL-12 produced by macrophages and dendritic cells [13] . Th1 commitment is enhanced by IFN-g, which upregulates the IL-12 receptor while inhibiting the growth of Th2 cells [3, 5, 9, 13] . IL-12-induced activation of signal transducer and activator of transcription 4 (Stat4) is critical for Th1 responses. Mice deficient in IL-12, the IL-12 receptor and Stat4, or IFN-g, interferon regulatory factor 1 (IRF-1) and IL-18 have markedly reduced Th1 responses (reviewed in [9] ). IL-18 has been shown to synergize with IL-12 for the production of IFN-g by Th1 cells (reviewed in [3, 14] ) and, furthermore, mice deficient in IL-18 or IL-12 show a defect in Th1 responses to bacterial challenge [15] . On the other hand, IL-4 induces Th2 development, via activation of Stat6, and mice deficient in IL-4 or Stat6 have impaired Th2 responses (reviewed in [3, 5, 9] ). IL-4 also downregulates IL-12 receptor expression on developing cells thereby facilitating their commitment to the Th2 lineage (reviewed in [3, 5, 9] ). Thus, a specific genetic program results in the differentiation towards either the Th1 or the Th2 lineage.
Significant progress has been made in identifying the transcription factors that control the development of a naïve CD4 + T-cell precursor into a Th2 cell. Two Th2-specific transcription factors, c-Maf and GATA-3, have been described [16] [17] [18] . c-Maf augments the induction of IL-4 by transactivation of the IL-4 promoter [16] , and c-Mafdeficient mice have impaired IL-4 production [19] . Ectopic expression of c-Maf, however, will not induce the expression of IL-4 in developing Th1 cells. GATA-3 plays a dominant role because it can induce a wide range of Th2-specific cytokines in developing [17, [20] [21] [22] and committed [22] Th1 cells, and GATA-3 can also inhibit the production of IFN-g [20] [21] [22] [23] . These events do not occur via transcriptional activation of the IL-4 promoter [22] , but in part via GATA-3-mediated downregulation of the b2 subunit of the IL-12 receptor [20] , and also via GATA-3-mediated effects on chromatin remodeling of the IL-4 locus [22, 23] .
In contrast, very little is known about the molecular basis of Th1 differentiation other than the required signaling pathways discussed above. The Ets family member Erm, which is induced by IL-12 in a Stat4-dependent manner, is expressed specifically in Th1 cells, but does not affect the production of Th1-specific cytokines [24] . The new study by Szabo et al. [12] describes the isolation of a novel protein belonging to the T-box family of transcription factors, which have critical roles in diverse developmental processes. Szabo et al. [12] have named their gene T-bet (T-box expressed in T cells) as it is selectively expressed in thymocytes and Th1 cells. T-bet was rapidly and selectively induced in T-cell precursors driven down the Th1 but not the Th2 pathway. Cotransfection of the mouse thymoma cell line EL4 with T-bet and a reporter gene driven by the promoter region of the IFN-g gene resulted in significant T-bet-specific transactivation of the reporter gene in both stimulated and unstimulated cells. In contrast, T-bet expression repressed the activity of the IL-2 promoter, which correlates with previous observations that, although Th1 cells express IL-2, these cells downregulate its expression as they differentiate. Interestingly, T-bet had no effect on IL-4 promoter transactivation.
Populations of B220 + cells, which comprise B cells and natural killer cells, upregulated T-bet upon culture with IL-12, and this expression was further enhanced by IL-18. Under conditions in which cells were stimulated by IL-12 and IL-18, significant levels of IFN-g production were observed, compared with those observed in the presence of either of the cytokines alone. This difference was observed even though T-bet was induced by IL-12. It is possible that IL-18 induces another factor required for IFN-g production [25] , or that T-bet has to be expressed above a certain threshold to achieve significant induction of IFN-g [12] . Indeed, dose-dependent effects on lineage determination have been observed for other transcription factors [26] . This proposal agrees with recent findings that, although ectopic expression of the b2 subunit of the IL-12 receptor in developing Th2 cells results in the ability of IL-12 to activate Stat4 and proliferation in these cells, it does not lead to significant production of IFN-g [27] .
Two main systems have been used for studying the factors that drive Th1 and Th2 development. The first involves polyclonal stimulation of T cells by, for example, triggering the T-cell receptor with antibodies against CD3 together with antibodies against the costimulator CD28. The second involves deriving T cells from transgenic mice expressing a specific T-cell receptor and stimulating them with the antigen recognised by this receptor in the context of antigen-presenting cells [3] . In such systems, retroviral infection of primary CD4 + T cells with T-bet resulted in a dramatic increase in the number of IFN-gproducing cells as compared with cells not expressing T-bet. Moreover, ectopic expression of T-bet in T cells cultured under conditions that would drive them towards a Th2 phenotype also gave rise to large numbers of IFN-gproducing cells, in contrast to the controls. In addition, introduction of T-bet into developing Th2 cells also led to a marked reduction in the number of IL-4-producing cells, and this decrease was independent of IFN-g signaling. Reversibility of Th1 and Th2 populations is largely abrogated after one week in culture, although stable commitment to a T helper phenotype occurs after three weeks of stimulation under polarizing conditions [28] . Remarkably, introduction of T-bet into such stably committed Th2 populations dramatically increased the numbers of IFNg-producing cells, and reduced the number of IL-4-and IL-5-producing cells [12] . Thus T-bet can convert Th2 cells into Th1 cells. Ectopic expression of T-bet in a homogeneous Th2 clone, however, only minimally increased the number of IFN-g-producing cells. This marginal effect may be because the chromatin configuration at the relevant loci is no longer accessible or because the array of factors necessary for inducing IFN-g gene expression is no longer present. T-bet expression in the Th2 clone still resulted in a significant reduction of IL-4-and IL-5-producing cells, however, showing that the ability of T-bet to suppress Th2 development extends even to long-term clones. T-bet therefore initiates Th1 genetic programs while repressing the opposing Th2 programs.
The effect of T-bet in repressing the Th2 program while simultaneously enhancing the Th1 program is reminiscent of GATA-3, which indirectly represses IFN-g expression [20, 21, 23] , while simultaneously inducing Th2 differentiation [17, 18, [20] [21] [22] [23] . Furthermore, it has recently been shown that GATA-3 will induce the production of IL-4 and IL-5 in committed Th1 cells [22] , and that it induces a Th2-specific DNase I hypersensitive site in the IL-4 locus in committed Th1 cells. The level of IL-4 induction by GATA-3 in committed Th1 cells is lower than in developing Th1 cells, similar to the reduced effect of T-bet on induction of IFN-g in the Th2 clone. This induction of IL-4 and IL-5 by GATA-3 is significantly enhanced by addition of cyclic AMP. Thus, the balance of T-bet or GATA-3 ultimately determines whether a developing T helper cell becomes a Th1 or Th2 cell, respectively, even though other factors are undoubtedly involved in fine-tuning this regulation.
